Synthèse de publications et de résultats cliniques

  • Eczéma
  • Psoriasis

Anti-inflammatory and immunomodulatory effects of Aquaphilus dolomiae extract on in vitro models

Marie-Françoise Aries, Hélène Hernandez-Pigeon, Clémence Vaissière, Hélène Delga, Antony Caruana, Marguerite Lévêque, Muriel Bourrain, Katia Ravard Helffer, Bertrand Chol, Thien Nguyen, Sandrine Bessou-Touya, Nathalie Castex-Rizzi
Clinical, Cosmetic and Investigational Dermatology
2016
Voir la publication
  • Eczéma
  • Psoriasis

A cream based on Aquaphilus dolomiae extracts alleviates non-histaminergic pruritus in humans

Anna Chiara FOSTINI, Victor GEORGESCU, Catherine Jean DECOSTER, Giampiero GIROLOMONI
European Journal of Dermatology
2017
Voir la publication
  • Eczéma
  • Psoriasis

Visualization of dendritic cells’ responses in atopic dermatitis: Preventing effect of emollient

Céline Mias, Jimmy Le Digabel, Jérôme Filiol, Etienne Gontier, Eléonore Gravier, Aurélie Villaret, Thérèse Nocera, Emmanuel Questel, Ana-Beatris Rossi, Daniel Redoulès, Gwendal Josse
Experimental Dermatology
2017
Voir la publication
  • Eczéma
  • Psoriasis

An Emollient Containing Aquaphilus dolomiae Extract is Effective in the Management of Xerosis and Pruritus: An International, Real-World Study

Mette Deleuran, Victor Georgescu, Catherine Jean-Decoster
Dermatologic Therapy
2020
Voir la publication
  • Eczéma
  • Psoriasis

An emollient PLUS balm is useful for the management of xerosis in cancer-treated patients: a real-world, prospective, observational, multicenter study

Véronique Vendrely, Ander Mayor Ibarguren, Aline Stennevin, Ariadna Ortiz-Brugués
Dermatologic and Therapy Journal
2022
Voir la publication
  • Eczéma

An emollient PLUS balm is useful for the management of xerosis in cancer-treated patients: a real-world, prospective, observational, multicenter study

This emollient was effective at reducing the severity of xerosis and other clinical symptoms, and at lessening the impact of skin manifestations on patient quality of life, regardless of the anticancer therapy received by the…
Véronique Vendrely, Ander Mayor Ibarguren, Aline Stennevin, Ariadna Ortiz-Brugués
Dermatologic and Therapy Journal
2022
Voir la publication